NCIt related terms : MET/VEGFR-2 inhibitor GSK1363089; XL880;
NCIt definition : An orally bioavailable small molecule with potential antineoplastic activity. Foretinib
binds to and selectively inhibits hepatocyte growth factor (HGF) receptor c-MET and
vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition
of tumor angiogenesis, tumor cell proliferation and metastasis. The proto-oncogene
c-MET has been found to be over-expressed in a variety of cancers. VEGFR2 is found
on endothelial and hematopoietic cells and mediates the development of the vasculature
and hematopoietic cells through VEGF signaling.;
Alternative definition : NCI-GLOSS: A substance being studied in the treatment of cancer. Foretinib blocks
enzymes involved in the growth and spread of tumor cells. It may also prevent the
growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase
inhibitor and a type of antiangiogenesis agent.;
UNII : 81FH7VK1C4;
InChIKey : CXQHYVUVSFXTMY-UHFFFAOYSA-N;
CAS number : 849217-64-7;
Molecule name : GSK1363089; XL880;
Chemical formula : C34H34F2N4O6;
Codes from synonyms : CDR0000549701; CDR0000666675; CDR0000675317;